The Racing Medication and Testing Consortium board of directors has approved new national laboratory standards for testing, the implementation of a laboratory accreditation program and a new independent Equine Quality Assurance Program.
Time and money are two of the major roadblocks as the horse racing industry struggles to come to terms with medication, drug testing, and security, officials said March 4 during the joint annual meeting of Harness Tracks of America and the Thoroughbred Racing Associations.
Testing of post race samples for erythropoietin and darbepoietin antibodies will begin Nov. 1 in New York under an emergency rule approved Oct. 21 by the state's Racing and Wagering Board.
Most Popular Stories
- Blazing Speed Wins QE II Cup in Hong Kong
- Two Derby Hopefuls Boast Derby-Winning Sires
- Calumet Farm: The Rebirth of a Legend
- Dortmund Runs Easy in Final Derby Drill
- Mubtaahij in 'Missed Work' at Arlington
- Carpe Diem Solid in Final Pre-Derby Work
- No Catching Cinco Charlie in William Walker
- StarLadies On Oaks Trail With Eskenformoney
- Effinex Wins Excelsior, Wicked Strong Third
- Longshot Si Sage Stuns Field in Last Tycoon